Peripheral Blood Eosinophils and Nine Years Mortality in COPD Patients

References

• Persson LJ, Aanerud M, Hiemstra PS, Hardie JA, Bakke PS, Eagan TML. Chronic obstructive pulmonary disease is associated with low levels of vitamin D. PLoS One. 2012;7(6):e38934. doi:10.1371/journal.pone.0038934
   PubMed Web of Science ®Google Scholar
• Kita H. Eosinophils: multifunctional and distinctive properties. Int Arch Allergy Immunol. 2013;161(s2):3–9. doi:10.1159/000350662
   PubMed Web of Science ®Google Scholar
• Furuta GT, Atkins FD, Lee NA, Lee JJ. Changing roles of eosinophils in health and disease. Ann Allergy Asthma Immunol. 2014;113(1):3–8. doi:10.1016/j.anai.2014.04.002
   PubMed Web of Science ®Google Scholar
• Bafadhel M, Pavord ID, Russell REK. Eosinophils in COPD: just another biomarker? Lancet Respir Med. 2017;5(9):747–759. doi:10.1016/S2213-2600(17)30217-5
   PubMed Web of Science ®Google Scholar
• Saetta M, Di stefano AN, Maestrelli P, et al. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med. 1995;152(6 Pt 1):1926–1931. doi:10.1164/ajrccm.152.6.8520757
   PubMedGoogle Scholar
• Queiroz CF, Lemos ACM, Bastos MLS, et al. Inflammatory and immunological profiles in patients with COPD: relationship with FEV 1 reversibility. J Bras Pneumol. 2016;42(4):241–247. doi:10.1590/s1806-37562015000000122
   PubMed Web of Science ®Google Scholar
• Tashkin DP, Wechsler ME. Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2018;13:335–349. doi:10.2147/COPD.S152291
   PubMed Web of Science ®Google Scholar
• Saha S, Brightling CE. Eosinophilic airway inflammation in COPD. Int J Chron Obstruct Pulmon Dis. 2006;1(1):39–47. doi:10.2147/copd.2006.1.1.39
   PubMedGoogle Scholar
• Eltboli O, Bafadhel M, Hollins F, et al. COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils. BMC Pulm Med. 2014;14(1):112. doi:10.1186/1471-2466-14-112
   PubMedGoogle Scholar
• Pizzichini E, Pizzichini MM, Gibson P, et al. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med. 1998;158(5):1511–1517. doi:10.1164/ajrccm.158.5.9804028
   PubMed Web of Science ®Google Scholar
• Pavord ID, Lettis S, Anzueto A, Barnes N. Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis. Lancet Respir Med. 2016;4(9):731–741. doi:10.1016/S2213-2600(16)30148-5
   PubMed Web of Science ®Google Scholar
• Pascoe S, Locantore N, Dransfield MT, Barnes NC, Pavord ID. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med. 2015;3(6):435–442. doi:10.1016/S2213-2600(15)00106-X
   PubMed Web of Science ®Google Scholar
• Watz H, Tetzlaff K, Wouters EF, et al. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial. Lancet Respir Med. 2016;4(5):390–398. doi:10.1016/S2213-2600(16)00100-4
   PubMed Web of Science ®Google Scholar
• Prudente R, Franco EAT, Mesquita CB, Ferrari R, de Godoy I, Tanni SE. Predictors of mortality in patients with COPD after 9 years. Int J Chron Obstruct Pulmon Dis. 2018;13:3389–3398. doi:10.2147/COPD.S174665
   PubMed Web of Science ®Google Scholar
• Hulley SB, Cummings SR, Browner WS, Grady DG, Newman TB. Delineando a Pesquisa Clínica. Porto Alegre: Artmed; 2015.
   Google Scholar
• Holland M, Alkhalil M, Chandromouli S, Janjua A, Babores M. Eosinopenia as a marker of mortality and length of stay in patients admitted with exacerbations of chronic obstructive pulmonary disease. Respirology. 2010;15(1):165–167. doi:10.1111/j.1440-1843.2009.01651.x
   PubMed Web of Science ®Google Scholar
• Steer J, Gibson J, Bourke SC. The DECAF score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax. 2012;67(11):970–976. doi:10.1136/thoraxjnl-2012-202103
   PubMed Web of Science ®Google Scholar
• Rahimi-Rad MH, Asgari B, Hosseinzadeh N, Eishi A. Eosinopenia as a marker of outcome in acute exacerbations of chronic obstructive pulmonary disease. Maedica (Buchar). 2015;10:10–13.
   PubMedGoogle Scholar
• Mendy A, Forno E, Niyonsenga T, Gasana J. Blood biomarkers as predictors of long-term mortality in COPD. Clin Respir J. 2018;12(5):1891–1899. doi:10.1111/crj.12752
   PubMed Web of Science ®Google Scholar
• Ho J, He W, Chan MTV, et al. Eosinophilia and clinical outcome of chronic obstructive pulmonary disease: a meta-analysis. Sci Rep. 2017;7(1):13451. doi:10.1038/s41598-017-13745-x
   PubMed Web of Science ®Google Scholar
• Zysman M, Deslee G, Caillaud D, et al. Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:1819–1824. doi:10.2147/COPD.S129787
   PubMed Web of Science ®Google Scholar
• Adir Y, Hakrush O, Shteinberg M, Schneer S, Agusti A. Circulating eosinophil levels do not predict severe exacerbations in COPD: a retrospective study. ERJ Open Res. 2018;4(3):00022–2018. doi:10.1183/23120541.00022-2018
   PubMedGoogle Scholar
• Low EV, Hughes SM, Zaffarullah S, Kantas D, Stockley RA, Turner AM. ICS use may modify FEV1 decline in α1-antitrypsin deficiency patients with relatively high blood eosinophils. Respiration. 2018;95(2):114–121. doi:10.1159/000481867
   PubMed Web of Science ®Google Scholar
• Bafadhel M, Greening NJ, Harvey-Dunstan TC, et al. Blood eosinophils and outcomes in severe hospitalized exacerbations of COPD. Chest. 2016;150(2):320–328. doi:10.1016/j.chest.2016.01.026
   PubMed Web of Science ®Google Scholar
• Tsiligianni I, Kaplan AG. Are blood eosinophils a prime-time biomarker for COPD management decisions? Int J Chron Obstruct Pulmon Dis. 2018;13:1889–1891. doi:10.2147/COPD.S163749
   PubMed Web of Science ®Google Scholar
• Klion AD. Eosinophilia: a pragmatic approach to diagnosis and treatment. Hematology Am Soc Hematol Educ Program. 2015;2015(1):92–97. doi:10.1182/asheducation-2015.1.92
   PubMedGoogle Scholar
• Tsiligianni IG, Kosmas E, Van der Molen T, Tzanakis N. Managing comorbidity in COPD: a difficult task. Curr Drug Targets. 2013;14(2):158–176. doi:10.2174/1389450111314020004
   PubMed Web of Science ®Google Scholar
• Nutman TB. Evaluation and differential diagnosis of marked, persistent eosinophilia. Immunol Allergy Clin North Am. 2007;27(3):529–549. doi:10.1016/j.iac.2007.07.008
   PubMed Web of Science ®Google Scholar
• Fernandes FLA. Eosinophils in COPD: why should I care? J Bras Pneumol. 2016;42(4):237–238. doi:10.1590/s1806-37562016000400001
   PubMed Web of Science ®Google Scholar
• Liu H, Lazarus SC, Caughey GH, Fahy JV. Neutrophil elastase and elastase-rich cystic fibrosis sputum degranulate human eosinophils in vitro. Am J Physiol. 1999;276:28–34.
   Web of Science ®Google Scholar
• Costa CH, Rufino R, Silva JRL. Células inflamatórias e seus mediadores na patogênese da DPOC. Rev Assoc Med Bras. 2009;55(3):347–354. doi:10.1590/S0104-42302009000300031
   PubMedGoogle Scholar
• Hospers JJ, Schouten JP, Weiss ST, Rijcken B, Postma DS. Asthma attacks with eosinophilia predict mortality from chronic obstructive pulmonary disease in a general population sample. Am J Respir Crit Care Med. 1999;160(6):1869–1874. doi:10.1164/ajrccm.160.6.9811041
   PubMed Web of Science ®Google Scholar
• Singh D, Kolsum U, Brightling CE, Locantore N, Agusti A, Tal-Singer R; ECLIPSE investigators. Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur Respir J. 2014;44(6):1697–1700. doi:10.1183/09031936.00162414
   PubMed Web of Science ®Google Scholar
• Oshagbemi OA, Burden AM, Braeken DCW, et al. Stability of blood eosinophils in patients with chronic obstructive pulmonary disease and in control subjects, and the impact of sex, age, smoking, and baseline counts. Am J Respir Crit Care Med. 2017;195(10):1402–1404. doi:10.1164/rccm.201701-0009LE
   PubMed Web of Science ®Google Scholar
• Shin SH, Park HY, Kang D, et al.; KOLD Study Group. Serial blood eosinophils and clinical outcome in patients with chronic obstructive pulmonary disease. Respir Res. 2018;19(1):134. doi:10.1186/s12931-018-0840-x
   PubMed Web of Science ®Google Scholar